HCA Healthcare, Inc. (HCA) Annual Reports
HCA Healthcare, Inc. is listed on NYSE, classified by the SEC under Services-General Medical & Surgical Hospitals, NEC (SIC 8062). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.
Company profile
- Exchange： NYSE
- Fiscal year end： 12/31
- SEC CIK： 860730 →
Website：Official site ↗
Financial Highlights
| Current | Prior year | YoY | |
|---|---|---|---|
| Revenue | $19.1B | $18.3B | +4.3% |
| Net income | $1.6B | $1.6B | +0.6% |
| EPS (diluted) | $7.15 | $6.45 | +10.9% |
Source: SEC EDGAR (XBRL company facts)
Financial history
Revenue & profit
Quarterly · In bn (USD)
Revenue 19.1 bn
Net income 1.62 bn
Show table：Income statement
| Item | 2009Q4 | 2010Q1 | 2010Q2 | 2010Q3 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 41.5 | 10.6 | 10.7 | 10.7 | 11.6 | 11.4 | 11.5 | 11.4 | 12.3 | 12.5 | 12.6 | 12.7 | 13.5 | 12.9 | 11.1 | 13.3 | 14.3 | 14.0 | 14.4 | 15.3 | 15.1 | 14.9 | 14.8 | 15.0 | 15.5 | 15.6 | 15.9 | 16.2 | 17.3 | 17.3 | 17.5 | 17.5 | 18.3 | 18.3 | 18.6 | 19.2 | 19.5 | 19.1 |
| Net income | 1.05 | 0.39 | 0.29 | 0.24 | 0.28 | 0.24 | 0.23 | 0.06 | 1.94 | 0.54 | 0.39 | 0.36 | 0.31 | 0.34 | 0.42 | 0.37 | 0.42 | 0.35 | 0.48 | 0.52 | 0.53 | 0.59 | 0.51 | 0.45 | 0.58 | 0.69 | 0.66 | 0.62 | 0.92 | 0.66 | 0.66 | 0.43 | 0.47 | 1.14 | 0.82 | 0.76 | 1.06 | 1.04 | 0.78 | 0.61 | 1.07 | 0.58 | 1.08 | 0.67 | 1.43 | 1.42 | 1.45 | 2.27 | 1.81 | 1.27 | 1.16 | 1.13 | 2.08 | 1.36 | 1.19 | 1.08 | 1.61 | 1.59 | 1.46 | 1.27 | 1.44 | 1.61 | 1.65 | 1.64 | 1.88 | 1.62 |
Balance sheet
Quarterly · In bn (USD)
Total assets 61.5 bn
Total liabilities 45.6 bn
Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.
Show table：Balance sheet
| Item | 2009Q4 | 2010Q1 | 2010Q2 | 2010Q3 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | — | — | — | — | 6.92 | 6.99 | 6.89 | 6.69 | 7.23 | 7.28 | 7.14 | 7.27 | 7.76 | 7.79 | 7.79 | 7.77 | 8.04 | 8.88 | 8.77 | 8.53 | 8.93 | 9.13 | 9.29 | 9.22 | 9.23 | 9.20 | 9.10 | 8.84 | 9.09 | 9.04 | 9.34 | 9.45 | 9.98 | 10.4 | 10.4 | 10.0 | 10.2 | 11.1 | 12.9 | 10.8 | 11.2 | 11.0 | 14.0 | 16.3 | 12.3 | 12.0 | 12.5 | 13.3 | 13.5 | 15.0 | 13.9 | 13.5 | 13.6 | 13.5 | 13.9 | 14.3 | 14.9 | 15.3 | 15.2 | 16.7 | 16.4 | 16.3 | 15.6 | 15.3 | 15.8 | 16.1 |
| Total assets | — | — | — | — | 23.9 | 23.8 | 23.9 | 23.8 | 26.9 | 27.1 | 27.1 | 27.3 | 28.1 | 27.9 | 27.9 | 28.4 | 28.8 | 29.8 | 29.8 | 29.8 | 31.2 | 31.3 | 31.7 | 31.9 | 32.7 | 32.8 | 33.2 | 33.1 | 33.8 | 33.8 | 34.6 | 35.7 | 36.6 | 37.3 | 37.7 | 38.0 | 39.2 | 43.4 | 45.5 | 43.9 | 45.1 | 45.4 | 48.7 | 51.0 | 47.5 | 47.3 | 48.2 | 49.6 | 50.7 | 52.2 | 51.6 | 51.5 | 52.4 | 52.7 | 53.6 | 54.6 | 56.2 | 57.0 | 57.4 | 59.5 | 59.5 | 59.8 | 59.5 | 59.8 | 60.7 | 61.5 |
| Current liabilities | — | — | — | — | 4.27 | 4.27 | 4.28 | 4.27 | 5.55 | 5.62 | 5.45 | 5.86 | 6.17 | 5.99 | 6.02 | 5.42 | 5.70 | 5.89 | 5.90 | 5.63 | 5.48 | 7.17 | 6.31 | 6.31 | 5.52 | 5.40 | 5.40 | 5.16 | 5.83 | 5.46 | 5.77 | 5.61 | 6.16 | 7.48 | 7.63 | 6.23 | 7.57 | 10.5 | 8.96 | 7.12 | 7.76 | 7.02 | 12.9 | 14.4 | 8.70 | 8.64 | 8.62 | 9.62 | 9.58 | 10.5 | 9.00 | 9.78 | 9.90 | 11.0 | 11.6 | 12.4 | 12.7 | 13.1 | 14.3 | 14.9 | 15.2 | 13.6 | 15.9 | 17.9 | 16.4 | 19.3 |
| Total liabilities | — | — | — | — | — | — | — | — | 33.9 | 34.5 | 34.1 | 33.9 | 36.4 | 35.9 | 35.4 | 35.4 | 35.8 | 36.3 | 36.4 | 35.8 | 37.7 | 37.5 | 37.7 | 37.7 | 38.8 | 38.8 | 39.7 | 39.3 | 39.4 | 39.1 | 39.6 | 40.8 | 41.6 | 41.7 | 41.9 | 41.8 | 42.1 | 45.6 | 47.2 | 45.4 | 45.6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity | -7.98 | — | — | — | -11.9 | -8.93 | -8.68 | -10.2 | 8.26 | -8.61 | -8.24 | -7.86 | -9.66 | -9.32 | -8.82 | -8.38 | -8.27 | -7.83 | -7.99 | -7.38 | -7.89 | -7.62 | -7.41 | -7.29 | -7.60 | -7.56 | -8.11 | -7.76 | -7.30 | -7.02 | -6.79 | -6.78 | -6.81 | -6.24 | -5.99 | -5.60 | -4.95 | -4.35 | -3.90 | -3.56 | -2.81 | -2.96 | -1.79 | -0.97 | 0.57 | 0.25 | -0.59 | -0.69 | -0.93 | -2.03 | -3.68 | -3.37 | -2.77 | -2.49 | -2.30 | -2.48 | -1.77 | -1.61 | -1.60 | -2.18 | -2.50 | -3.52 | -4.39 | -5.33 | -6.03 | -6.30 |
Cash flow
Quarterly · In bn (USD)
Operating 2.01 bn
Investing -1.28 bn
Financing -0.83 bn
Positive = cash in, negative = cash out.
Show table：Cash flow statement
| Item | 2009Q4 | 2010Q1 | 2010Q2 | 2010Q3 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2.75 | 0.86 | 0.44 | 1.26 | 0.53 | 0.92 | 0.75 | 0.88 | 1.39 | 0.8 | 1.46 | 0.66 | 1.26 | 0.74 | 0.81 | 0.9 | 1.23 | 0.44 | 1.25 | 1.13 | 1.63 | 1.02 | 1.06 | 1.10 | 1.56 | 1.40 | 1.35 | 1.21 | 1.70 | 1.28 | 1.40 | 1.01 | 1.73 | 1.28 | 1.58 | 1.72 | 2.17 | 0.97 | 2.00 | 2.13 | 2.51 | 1.38 | 8.72 | 2.72 | -3.58 | 1.99 | 2.25 | 2.28 | 2.44 | 1.35 | 1.63 | 3.02 | 2.53 | 1.80 | 2.48 | 2.48 | 2.67 | 2.47 | 1.97 | 3.52 | 2.56 | 1.65 | 4.21 | 4.42 | 2.36 | 2.01 |
| Investing | -1.03 | -0.18 | 0.13 | -0.35 | -0.64 | -0.27 | -0.54 | -0.43 | -1.75 | -0.44 | -0.45 | -0.45 | -0.72 | -0.37 | -0.42 | -0.88 | -0.67 | -0.41 | -0.45 | -0.65 | -1.41 | -0.43 | -0.58 | -0.62 | -0.95 | -0.5 | -1.06 | -0.68 | -1.01 | -0.67 | -0.92 | -1.58 | -1.11 | -0.33 | -0.98 | -1.30 | -1.29 | -2.16 | -0.95 | -1.26 | -1.34 | -1.14 | -0.81 | -0.53 | -0.91 | -0.65 | -0.92 | 0.64 | -1.71 | -0.84 | -1.20 | -0.55 | -0.79 | -1.15 | -1.26 | -1.31 | -1.60 | -0.9 | -1.33 | -1.35 | -1.35 | -1.03 | -1.25 | -1.39 | -1.32 | -1.28 |
| Financing | -1.86 | -0.6 | -0.6 | -0.88 | 0.14 | -0.5 | -0.22 | -0.63 | 0.38 | -0.26 | -0.96 | -0.25 | -0.31 | -0.48 | -0.53 | 0.01 | -0.62 | 0.4 | -0.99 | -0.62 | -0.17 | -0.57 | -0.39 | -0.56 | -0.45 | -0.79 | -0.45 | -0.54 | -0.72 | -0.5 | -0.53 | 0.59 | -0.61 | -0.61 | -0.8 | -0.71 | -0.96 | 1.22 | 0.85 | -2.73 | -1.11 | -0.11 | -4.01 | -0.24 | -0.32 | -2.10 | -1.24 | -3.00 | -0.31 | 0.43 | -1.93 | -2.32 | -1.84 | -0.72 | -1.20 | -1.13 | -1.04 | -1.22 | -1.09 | -0.11 | -2.16 | -1.49 | -3.09 | -2.97 | -1.00 | -0.83 |
| Cash at period end | 0.31 | 0.39 | 0.35 | 0.38 | 0.41 | 0.55 | 0.54 | 0.36 | 0.37 | 0.47 | 0.52 | 0.47 | 0.71 | 0.59 | 0.46 | 0.48 | 0.41 | 0.85 | 0.66 | 0.52 | 0.57 | 0.59 | 0.67 | 0.59 | 0.74 | 0.85 | 0.69 | 0.68 | 0.65 | 0.75 | 0.71 | 0.72 | 0.73 | 1.09 | 0.87 | 0.58 | 0.5 | 0.53 | 2.43 | 0.56 | 0.62 | 0.73 | 4.64 | 6.59 | 1.79 | 1.03 | 1.12 | 1.03 | 1.45 | 2.37 | 0.86 | 1.00 | 0.91 | 0.84 | 0.86 | 0.89 | 0.94 | 1.28 | 0.83 | 2.89 | 1.93 | 1.06 | 0.94 | 1.00 | 1.04 | 0.94 |
Profitability
Quarterly · %
Net margin 8.5%
Gross, operating and net margin = the respective profit ÷ revenue.
Show table：Profitability
| Item | 2009Q4 | 2010Q1 | 2010Q2 | 2010Q3 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.2% | 6.2% | 6.1% | 4.0% | 4.1% | 10.0% | 7.1% | 6.6% | 8.7% | 8.3% | 6.2% | 4.8% | 7.9% | 4.5% | 9.8% | 5.0% | 10.0% | 10.2% | 10.1% | 14.8% | 12.0% | 8.5% | 7.8% | 7.6% | 13.4% | 8.7% | 7.5% | 6.7% | 9.3% | 9.2% | 8.3% | 7.3% | 7.9% | 8.8% | 8.9% | 8.6% | 9.6% | 8.5% |
Returns & leverage
Quarterly · %
ROA 11.2%
Debt ratio 101.3%
ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.
Show table：Returns & leverage
| Item | 2009Q4 | 2010Q1 | 2010Q2 | 2010Q3 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | — | — | — | — | 5.1% | 4.5% | 4.2% | 3.4% | 9.7% | 10.8% | 11.5% | 12.6% | 5.8% | 5.1% | 5.2% | 5.2% | 5.5% | 5.4% | 5.6% | 6.1% | 6.3% | 6.9% | 7.0% | 6.7% | 6.7% | 7.0% | 7.3% | 7.8% | 8.7% | 8.6% | 8.4% | 7.7% | 6.3% | 7.6% | 7.9% | 8.7% | 10.0% | 9.1% | 8.8% | 8.5% | 8.3% | 6.9% | 7.1% | 7.2% | 8.1% | 9.9% | 10.3% | 13.1% | 14.2% | 13.7% | 13.1% | 10.6% | 10.9% | 10.9% | 11.0% | 10.8% | 9.7% | 10.0% | 10.3% | 10.4% | 9.9% | 9.9% | 10.2% | 10.6% | 11.3% | 11.2% |
| Debt ratio | — | — | — | — | — | — | — | — | 126.1% | 127.0% | 125.6% | 124.0% | 129.7% | 128.7% | 126.8% | 124.8% | 124.0% | 121.7% | 122.1% | 120.2% | 120.8% | 119.9% | 118.8% | 118.2% | 118.5% | 118.3% | 119.6% | 118.6% | 116.7% | 115.8% | 114.7% | 114.2% | 113.7% | 111.9% | 110.9% | 109.8% | 107.4% | 105.2% | 103.9% | 103.3% | 101.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
EPS
Quarterly · US$
EPS US$7.15
Show table：EPS
| Item | 2009Q4 | 2010Q1 | 2010Q2 | 2010Q3 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS（US$） | 2.44 | 0.89 | 0.67 | 0.55 | 0.65 | 0.52 | 0.43 | 0.11 | 4.25 | 1.18 | 0.85 | 0.78 | 0.68 | 0.74 | 0.91 | 0.79 | 0.92 | 0.76 | 1.07 | 1.16 | 1.19 | 1.36 | 1.18 | 1.05 | 1.40 | 1.69 | 1.65 | 1.59 | 2.39 | 1.74 | 1.75 | 1.15 | 1.30 | 3.18 | 2.31 | 2.15 | 3.01 | 2.97 | 2.25 | 1.76 | 3.09 | 1.69 | 3.16 | 1.95 | 4.14 | 4.14 | 4.36 | 7.00 | 5.73 | 4.14 | 3.90 | 3.91 | 7.18 | 4.85 | 4.29 | 3.91 | 5.90 | 5.93 | 5.53 | 4.88 | 5.63 | 6.45 | 6.83 | 6.96 | 8.10 | 7.15 |
Revenue & profit
Year-to-date · In bn (USD)
Revenue 19.1 bn
Net income 1.62 bn
Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.
Balance sheet
Year-to-date · In bn (USD)
Total assets 61.5 bn
Total liabilities 45.6 bn
Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.
Cash flow
Year-to-date · In bn (USD)
Operating 2.01 bn
Investing -1.28 bn
Financing -0.83 bn
Positive = cash in, negative = cash out.
Profitability
Year-to-date · %
Net margin 8.5%
Gross, operating and net margin = the respective profit ÷ revenue.
Returns & leverage
Year-to-date · %
ROA 11.2%
Debt ratio 101.3%
ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.
EPS
Year-to-date · US$
EPS US$7.15
Revenue & profit
Annual · In bn (USD)
Revenue 75.6 bn
Net income 6.78 bn
Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.
Show table：Income statement
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 43.6 | 46.7 | 51.3 | 51.5 | 58.8 | 60.2 | 65.0 | 70.6 | 75.6 |
| Net income | 1.21 | 2.47 | 1.61 | 1.56 | 1.88 | 2.13 | 2.89 | 2.22 | 3.79 | 3.51 | 3.75 | 6.96 | 5.64 | 5.24 | 5.76 | 6.78 |
Balance sheet
Annual · In bn (USD)
Total assets 60.7 bn
Total liabilities 45.6 bn
Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.
Show table：Balance sheet
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | 6.92 | 7.23 | 7.76 | 8.04 | 8.93 | 9.23 | 9.09 | 9.98 | 10.2 | 11.2 | 12.3 | 13.5 | 13.6 | 14.9 | 16.4 | 15.8 |
| Total assets | 23.9 | 26.9 | 28.1 | 28.8 | 31.2 | 32.7 | 33.8 | 36.6 | 39.2 | 45.1 | 47.5 | 50.7 | 52.4 | 56.2 | 59.5 | 60.7 |
| Current liabilities | 4.27 | 5.55 | 6.17 | 5.70 | 5.48 | 5.52 | 5.83 | 6.16 | 7.57 | 7.76 | 8.70 | 9.58 | 9.90 | 12.7 | 15.2 | 16.4 |
| Total liabilities | — | 33.9 | 36.4 | 35.8 | 37.7 | 38.8 | 39.4 | 41.6 | 42.1 | 45.6 | — | — | — | — | — | — |
| Equity | -11.9 | 8.26 | -9.66 | -8.27 | -7.89 | -7.60 | -7.30 | -6.81 | -4.95 | -2.81 | 0.57 | -0.93 | -2.77 | -1.77 | -2.50 | -6.03 |
Cash flow
Annual · In bn (USD)
Operating 12.6 bn
Investing -4.99 bn
Financing -8.55 bn
Positive = cash in, negative = cash out.
Show table：Cash flow statement
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3.09 | 3.93 | 4.18 | 3.68 | 4.45 | 4.73 | 5.65 | 5.43 | 6.76 | 7.60 | 9.23 | 8.96 | 8.52 | 9.43 | 10.5 | 12.6 |
| Investing | -1.04 | -2.99 | -2.06 | -2.35 | -2.92 | -2.58 | -3.24 | -4.28 | -3.90 | -5.72 | -3.39 | -2.64 | -3.39 | -5.32 | -4.93 | -4.99 |
| Financing | -1.95 | -0.98 | -1.78 | -1.62 | -1.38 | -1.98 | -2.51 | -1.06 | -3.07 | -1.77 | -4.68 | -6.65 | -5.66 | -4.09 | -4.58 | -8.55 |
| Cash at period end | 0.41 | 0.37 | 0.71 | 0.41 | 0.57 | 0.74 | 0.65 | 0.73 | 0.5 | 0.62 | 1.79 | 1.45 | 0.91 | 0.94 | 1.93 | 1.04 |
Profitability
Annual · %
Net margin 9.0%
Gross, operating and net margin = the respective profit ÷ revenue.
Show table：Profitability
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | — | — | — | — | — | — | — | 5.1% | 8.1% | 6.8% | 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
Returns & leverage
Annual · %
ROA 11.3%
Debt ratio 101.3%
ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.
Show table：Returns & leverage
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 5.1% | 9.7% | 5.8% | 5.5% | 6.3% | 6.7% | 8.7% | 6.3% | 10.0% | 8.3% | 8.1% | 14.2% | 10.9% | 9.7% | 9.9% | 11.3% |
| Debt ratio | — | 126.1% | 129.7% | 124.0% | 120.8% | 118.5% | 116.7% | 113.7% | 107.4% | 101.3% | — | — | — | — | — | — |
EPS
Annual · US$
EPS US$28.34
Show table：EPS
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS（US$） | 2.76 | 5.31 | 3.49 | 3.36 | 4.18 | 4.99 | 7.32 | 5.94 | 10.65 | 10.07 | 10.94 | 21.23 | 19.13 | 18.95 | 21.97 | 28.34 |
Source: SEC EDGAR (XBRL company facts)
Annual reports by year
| 10-K | |
|---|---|
| 2025 | Open full text → |
| 2024 | Open full text → |
| 2023 | Open full text → |
10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.
FAQ
Where can I read HCA Healthcare, Inc. (HCA) annual reports?
Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.
What is the difference between a 10-K and a 20-F?
A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.
Are earnings call materials available here?
No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.
Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.
Back to US annual reports, or see the supply-chain maps.